SLC2A4 and breast cancer: GLUT4 downregulation may inhibit glucose uptake and induce metabolic reprogramming; research also found that GLUT4 downregulation can suppress cell proliferation and critically decrease cell viability under hypoxic conditions, especially in MCF7 and MDA-MB-231 breast cancer cells [33].